Pepteligence
Share

Research

Research index

Primary sources indexed across all peptides — grouped by evidence tier. 394 references total. How we evaluate evidence →

FDA ApprovedRegulatory-grade prescribing information from DailyMed.44 sources
Liraglutide2025
VICTOZA (liraglutide) injection, for subcutaneous use — Prescribing Information

U.S. Food and Drug Administration

FDA/DailyMed

Liraglutide2026
SAXENDA (liraglutide) injection, for subcutaneous use — Prescribing Information

U.S. Food and Drug Administration

FDA/DailyMed

Liraglutide2026
GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis

Sawicka-Gutaj N, Gruszczyński D, Nijakowski K, et al.

International Journal of Obesity

PMID 42034831
Liraglutide2023
Effect of liraglutide on cardiometabolic profile and on bioelectrical impedance analysis in patients with obesity and metabolic syndrome

Freitas FPC, Rodrigues CEM

Scientific Reports

PMID 37567946
Liraglutide2026
Efficacy of liraglutide on metabolic and reproductive outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis

Lu YT, Chang PH, Chen HJ, et al.

Diabetes, Obesity & Metabolism

PMID 41508932
Liraglutide2026
The Interplay Between GLP-1-Based Therapies, the Gut Microbiome, and MASLD/MASH in Type 2 Diabetes Mellitus: A Narrative Review

Dinkov B, Pendicheva-Duhlenska D

Biomedicines

PMID 42072347
Liraglutide2026
The Effect of Liraglutide on the Hypolipidemic, Anti-Inflammatory, and Antioxidant Properties of Atorvastatin Mediated via the Nrf2/HO-1 Signaling Pathway: In Vivo and In Silico Validation

Kamar SA, Magdy YM, Abuamara TMM, et al.

Pharmaceutics

PMID 42076140
Liraglutide2026
Non-arteritic anterior ischaemic optic neuropathy incidence in placebo-controlled clinical trials of liraglutide or semaglutide

Vilsbøll T, Arun Kumar Dikshit, Aiello LP, et al.

The British Journal of Ophthalmology

PMID 42049287
Liraglutide2026
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) in dermatology: cutaneous adverse events and emerging efficacy in inflammatory skin diseases

Ho MJ, Liew CF, Tan NS, et al.

Expert Review of Clinical Immunology

PMID 42043978
Liraglutide2022
Liraglutide Plus Dapagliflozin for High Uric Acid and Microalbuminuria in Diabetes Mellitus Complicated With Metabolic Syndrome

Ou T, Wang W, Yong H, et al.

Alternative Therapies in Health and Medicine

PMID 35751892
Liraglutide2026
The effects of GLP-1 receptor agonists on Alzheimer's pathophysiology: A systematic review

Corcoran E, Kettlety M, Mogul U, et al.

Molecular and Cellular Neurosciences

PMID 42014236
Liraglutide2022
Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca2+ abnormalities and mitochondrial dysfunction

Durak A, Akkus E, Canpolat AG, et al.

Clinical and Experimental Pharmacology & Physiology

PMID 34519087
Liraglutide2019
Effects of glucagon-like peptide-1 analog liraglutide on the systemic inflammation in high-fat-diet-induced mice

Sha S, Liu X, Zhao R, et al.

Endocrine

PMID 31542859
Liraglutide2026
Liraglutide Modulates Zinc Release and Improves Mitochondrial Function in Insulin-Resistant Senescent Cardiomyocytes

Hosseinpourshirazi F, Mendes UD, Aksoy ZB, et al.

Cardiovascular Toxicology

PMID 41604031
Liraglutide2025
Activation of cyclooxygenase-2 signaling mediates liraglutide-induced adipose lipolytic activity

Li J, Wu H, Ma W, et al.

European Journal of Pharmacology

PMID 40935112
Liraglutide2026
Three-year changes in renal function after switching from injectable GLP-1 receptor agonists to oral semaglutide in Japanese patients with type 2 diabetes: a retrospective cohort study

Takashima S, Terui K, Yamada F, et al.

Diabetology International

PMID 42078492
Liraglutide2026
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients with Type 2 Diabetes and Diabetic Retinopathy

Shah J, Makwana B, Panchal K, et al.

American Journal of Ophthalmology

PMID 42025665
Semaglutide2025
Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome.

MacIsaac Richard J

Future cardiology

PMID 40458885
Semaglutide2026
Real-World Comparison of Short-Term Adverse Events, Treatment Persistence, and Efficacy of Semaglutide and Tirzepatide: A Nationwide Multicenter Study.

Hepşen Sema, Haymana Cem, Ertepe Küçükgöde Gizem et al.

Obesity facts

PMID 42030208
Semaglutide2026
Glucagon-like peptide-1 and atrial fibrillation incidence: Associations independent of weight loss.

Palmisano Tiago, Verma Reeya, Guarraia David et al.

Heart rhythm

PMID 42029362
Semaglutide2026
Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: a phase 3, randomized, active-controlled trial (SIZE-DM study).

Kapoor Nitin, Shaikh Shehla, Bhattacharya Saptarshi et al.

Cardiovascular diabetology. Endocrinology reports

PMID 42026662
Semaglutide2026
Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly.

Ganeshalingam Ashok A, Uhrenholt Nicolai, Arnfred Sidse e…

Diabetes care

PMID 41778920
Semaglutide2026
LEAN mass Preservation with Resistance Exercise and Protein during semaglutide and tirzepatide therapy (LEAN-PREP study): a protocol for a randomised controlled trial.

Alawadhi Ameenah A, Alroudhan Dherar, Alsaeed Dalal J et al.

BMJ open

PMID 42020128
Semaglutide2026
Is There a Causal Link Between GLP-1 Receptor Agonists and Non-Arteritic Anterior Ischaemic Optic Neuropathy? A Critique of the Clinical Evidence.

Danesh-Meyer Helen V, Rizzo Joseph F

Clinical & experimental ophthalmology

PMID 42020100
Semaglutide2026
Semaglutide-Associated Acute Pancreatitis in a Patient With Type 2 Diabetes Mellitus: A Case Report.

Puri Piyush, Akhavan Michael, Shadan Jonathan et al.

Cureus

PMID 42017101
Semaglutide2026
Clinical outcomes of glucagon-like peptide-1 receptor agonist therapy in kidney transplant recipients: a systematic review and meta-analysis.

Kanbay Mehmet, Abdel-Rahman Sama Mahmoud, Guldan Mustafa …

Clinical kidney journal

PMID 42017027
Semaglutide2026
Differential Effects of Semaglutide and Colchicine on Atrial Remodeling in Rats with Reduced Ejection Fraction after Myocardial Infarction.

Levi Or, Dalal Noam, Komissar Aviv et al.

Europace

PMID 42015513
Semaglutide2026
Pilot study of epigenetic aging and treatment response to semaglutide in the SLIM LIVER study.

Corley Michael J, Pang Alina P S, Kitch Douglas W et al.

npj aging

PMID 42014432
Semaglutide2026
The effects of GLP-1 receptor agonists on Alzheimer's pathophysiology: A systematic review.

Corcoran Eve, Kettlety Michael, Mogul Urwa et al.

Molecular and cellular neurosciences

PMID 42014236
Semaglutide2026
Efficacy, Safety and PK of Once-Daily Oral Semaglutide 25 mg for Obesity With and Without Type 2 Diabetes in Comparison With Subcutaneous Semaglutide 2.4 mg: A Model-Informed Drug Development Approach.

Overgaard Rune Viig, Birkhan Oscar, Rathor Naveen et al.

Diabetes, obesity & metabolism

PMID 42023428
Semaglutide2026
Liver benefits of early initiation of low-dose GLP-1 receptor agonists in newly diagnosed type 2 diabetes - A case report.

Lee Joyce Y, Nguyen Huy, Nguyen Tan

Journal of family medicine and primary care

PMID 42023337
Semaglutide2026
Unexplained hypercapnia with normal pulmonary evaluation in a patient receiving semaglutide: a diagnostic challenge.

Prasad Sai, Ahuja Aarushi, Katwa Laxmansa C et al.

JCEM case reports

PMID 42027588
Semaglutide2026
Semaglutide for obesity management: A narrative review of efficacy, safety, and future directions.

Hajibandeh Saba, Tao Yen-An, Hsieh Ming-Hui et al.

Journal of the American Pharmacists Association : JAPhA

PMID 42025961
Semaglutide2026
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients with Type 2 Diabetes and Diabetic Retinopathy.

Shah Jui, Makwana Bhargav, Panchal Krisha et al.

American journal of ophthalmology

PMID 42025665
Semaglutide2021
Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide.

McLean Brent A, Wong Chi Kin, Kaur Kiran Deep et al.

JCI insight

PMID 34673572
Semaglutide2026
Effect of Weight-Neutral Treatment With Semaglutide or Tirzepatide on β-Cell Identity in db/db Mice.

Deng Zhaobin, Zheng Dongxu, Son Jinsook et al.

Acta physiologica (Oxford, England)

PMID 41354136
Semaglutide2026
NLRP3 inhibition by VTX3232 tempers inflammation resulting in reduced body weight, hyperglycemia, and hepatic steatosis in obese male mice.

Bultinck Jennyfer, Yuan Shendong, Cantuti-Castelvetri Lud…

Molecular metabolism

PMID 41242536
Semaglutide2026
Semaglutide-Mediated Remodeling of Adipose Tissue in Type 2 Diabetes: Molecular Mechanisms Beyond Glycemic Control.

Ábel Tatjana, Csobod Csajbókné Éva

International journal of molecular sciences

PMID 41683613
Semaglutide2025
The effect of Semaglutide on mitochondrial function and insulin sensitivity in a myotube model of insulin resistance.

Spry Emmalie R, Travis Kipton B, Ragland Kayla J et al.

Molecular and cellular endocrinology

PMID 40752656
Semaglutide2026
Body image in the age of GLP-1s: Emerging questions for research and practice.

Craddock Nadia, Schneider Jekaterina

Body image

PMID 42030632
Semaglutide2024
A feasibility study of the combination of intranasal insulin with oral semaglutide for cognition in older adults with metabolic syndrome at high dementia risk — Study rationale and design.

Davidy Tal, Yore Iscka, Cukierman-Yaffe Tali et al.

Mechanisms of ageing and development

PMID 38159613
Semaglutide2026
Weight loss as the optimal cardiometabolic management strategy for preventing and treating heart failure.

Costa Thomaz Alexandre, Vest Amanda R, Harrington Josephine

Current opinion in cardiology

PMID 41802118
Semaglutide2026
Dermatological and metabolic benefits of semaglutide in psoriasis with obesity: a 6-month prospective cohort study.

Nicolau Joana, Nadal Antoni, Sanchís Pilar et al.

Clinical and experimental dermatology

PMID 41137591
Semaglutide2026
GLP-1 Receptor Agonist Use and Wound Outcomes After Free Flap Breast Reconstruction.

Ha Joy, Lester Ethan, De May Henning et al.

Journal of reconstructive microsurgery

PMID 42013898
Phase 3 RCTsLarge-scale randomized controlled trials.102 sources
DSIP2006
Delta sleep-inducing peptide (DSIP): a still unresolved riddle.

Kovalzon Vladimir M, Strekalova Tatyana V

Journal of neurochemistry

PMID 16539679
DSIP1992
Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study.

Bes F, Hofman W, Schuur J et al.

Neuropsychobiology

PMID 1299794
DSIP1995
Human plasma DSIP decreases at the initiation of sleep at different circadian times.

Seifritz E, Müller M J, Schönenberger G A et al.

Peptides

PMID 8745061
DSIP1994
Diurnal rhythm of plasma delta-sleep-inducing peptide in humans: evidence for positive correlation with body temperature and negative correlation with rapid eye movement and slow wave sleep.

Friedman T C, Garcia-Borreguero D, Hardwick D et al.

The Journal of clinical endocrinology and metabolism

PMID 8175965
DSIP1995
Delta sleep-inducing peptide in normal humans and in patients with sleep apnea and narcolepsy.

Vgontzas A N, Friedman T C, Chrousos G P et al.

Peptides

PMID 8532601
DSIP1994
Decreased delta-sleep and plasma delta-sleep-inducing peptide in patients with Cushing syndrome.

Friedman T C, García-Borreguero D, Hardwick D et al.

Neuroendocrinology

PMID 7700506
DSIP1992
Delta-sleep-inducing peptide stimulates melatonin, 5-methoxytryptophol and serotonin secretion from perifused rat pineal glands.

Ouichou A, Zitouni M, Raynaud F et al.

Biological signals

PMID 1339175
DSIP1992
Implication of tryptophan in the stimulatory effect of delta-sleep-inducing peptide on indole secretion from perifused rat pineal glands.

Ouichou A, Pévet P

Biological signals

PMID 1307916
DSIP1986
Influence of delta-sleep inducing peptide on melatonin synthesis in the rat pineal gland.

Oaknin S, Troiani M E, Webb S M et al.

Neuroscience letters

PMID 3774211
DSIP1984
Modification of the hypothermic circadian cycles induced by DSIP and melatonin in pinealectomized and hypophysectomized rats.

Yehuda S, Mostofsky D I

Peptides

PMID 6548024
DSIP1988
The circadian cycle effects of DSIP on colonic temperature, blood pressure, and heart rate in control and area postrema-lesioned rats.

Yehuda S, Caspy T, Carasso R L

The International journal of neuroscience

PMID 3209378
DSIP1987
The effects of DSIP on pain threshold during light and dark periods in rats are not naloxone-sensitive.

Yehuda S, Carasso R L

The International journal of neuroscience

PMID 3679693
DSIP1993
Circadian effects of beta-endorphin, melatonin, DSIP, and amphetamine on pentylenetetrazol-induced seizures.

Yehuda S, Mostofsky D I

Peptides

PMID 8483798
DSIP1992
[The hypnogenic effects of delta sleep-inducing peptide (DSIP) analogs: a comparative study in rabbits and rats].

Koval'zon V M, Obal F, Alfoldi P et al.

Zhurnal evoliutsionnoi biokhimii i fiziologii

PMID 1455954
DSIP2001
[Hypnogenic properties of DSIP peptide analogs: structural-functional relationship].

Koval'zon V M

Izvestiia Akademii nauk. Seriia biologicheskaia

PMID 11525128
DSIP2021
DSIP-Like KND Peptide Reduces Brain Infarction in C57Bl/6 and Reduces Myocardial Infarction in SD Rats When Administered during Reperfusion.

Tukhovskaya Elena A, Shaykhutdinova Elvira R, Ismailova A…

Biomedicines

PMID 33918965
DSIP2021
Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke.

Tukhovskaya Elena A, Ismailova Alina M, Shaykhutdinova El…

Molecules (Basel, Switzerland)

PMID 34500605
DSIP2018
Phosphorylated delta sleep inducing peptide restores spatial memory and p-CREB expression by improving sleep architecture at high altitude.

Roy Koustav, Chauhan Garima, Kumari Punita et al.

Life sciences

PMID 30107169
DSIP2014
[Antioxidative and detoxifying effects of analogues of delta-sleep inducing peptide (DSIP)].

Mikhaleva I I, Ivanov V T, Onoprienko L V et al.

Bioorganicheskaia khimiia

PMID 25898718
DSIP2015
[THE INFLUENCE OF DELTA SLEEP-INDUCING PEPTIDE ON FUNCTIONAL STATE OF RATS HEPATOCYTES IN FOOT-SHOCK STRESS].

Belykh A E, Bobyntsev I I, Kryukov A A et al.

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova

PMID 26470489
DSIP2013
[Metabolic effects of delta-sleep inducing peptide during physiological aging of the organism].

Bondarenko T I, Maiboroda E A, Mikhaleva I I et al.

Eksperimental'naia i klinicheskaia farmakologiia

PMID 24432565
DSIP1997
Studies on the mechanism of the anticonvulsant effect of delta-sleep-inducing peptide in conditions of increased oxygen tension.

Mendzheritskii A M, Lysenko A V, Uskova N I et al.

Neuroscience and behavioral physiology

PMID 9406227
DSIP1992
Delta sleep-inducing-peptide-like immunoreactivity (DSIP-LI) and delta sleep in schizophrenic volunteers.

van Kammen D P, Widerlöv E, Neylan T C et al.

Sleep

PMID 1475566
DSIP1992
Plasma levels of DSIP in infants in the first year of life and SIDS risk.

Scholle S, Zwacka G, Ekman R et al.

Regulatory peptides

PMID 1579657
DSIP2008
[Endogenous anticonvulsants: neuropeptide Y and delta sleep inducing peptide].

Stanojlović Olivera, Hrnčić Dragan, Radosavljević Tatjana

Medicinski pregled

PMID 19102071
DSIP1994
Plasma concentration of nine hormones and neurotransmitters during usual activities or constant bed rest for 34 H.

Schulz P, Lustenberger S, Degli Agosti R et al.

Chronobiology international

PMID 7895296
DSIP2024
Pichia pastoris secreted peptides crossing the blood-brain barrier and DSIP fusion peptide efficacy in PCPA-induced insomnia mouse models.

Mu Xiaoxiao, Qu Lijun, Yin Liquan et al.

Frontiers in pharmacology

PMID 39444618
MK-6772026
Acute stress suppresses hunger-driven food seeking through PVN activation: Reversal by anxiolytic drug and ghrelin receptor agonist, with anxiolytic-like effects of refeeding.

Tojo Ryusei, Tashiro Mayuka, Takahashi Haruka et al.

Neuroscience research

PMID 41260416
MK-6772026
Knowing the minimal detectable dose can facilitate the interpretation of a hair test result: II. Case example with ibutamoren (MK-677), a growth hormone secretagogue.

Kintz Pascal, Gheddar Laurie

Clinica chimica acta; international journal of clinical chemistry

PMID 40882886
MK-6772025
Hepatotoxicity induced by MK-677.

Cobani Era, Amin Md Shahnoor, Hasso Muneer et al.

BMJ case reports

PMID 40675653
MK-6772024
Reversible Gynecomastia and Hypogonadism Due to Usage of Commercial Performance-Enhancing Supplement Use.

Chong Serena, Woolnough Catherine A, Koyyalamudi Sundar R…

JCEM case reports

PMID 39145153
MK-6772022
LGD-4033 and MK-677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report.

Cardaci Thomas D, Machek Steven B, Wilburn Dylan T et al.

Experimental physiology

PMID 36303408
MK-6772020
Brain and kidney GHS-R1a underexpression is associated with changes in renal function and hemodynamics during neurogenic hypertension.

Sales da Silva Elder, Ferreira Patrícia Maria, Castro Car…

Molecular and cellular endocrinology

PMID 32814069
MK-6772018
Effect of the Orally Active Growth Hormone Secretagogue MK-677 on Somatic Growth in Rats.

Lee Junghun, Kwon Ahreum, Chae Hyun Wook et al.

Yonsei medical journal

PMID 30450851
MK-6772009
Growth hormone secretagogues and growth hormone releasing peptides act as orthosteric super-agonists but not allosteric regulators for activation of the G protein Galpha(o1) by the Ghrelin receptor.

Bennett Kirstie A, Langmead Christopher J, Wise Alan et al.

Molecular pharmacology

PMID 19625579
MK-6772008
Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.

Sevigny J J, Ryan J M, van Dyck C H et al.

Neurology

PMID 19015485
MK-6772008
Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.

Nass Ralf, Pezzoli Suzan S, Oliveri Mary Clancy et al.

Annals of internal medicine

PMID 18981485
MK-6772009
Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor.

Holst Birgitte, Frimurer Thomas M, Mokrosinski Jacek et al.

Molecular pharmacology

PMID 18923064
MK-6772005
Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling.

Holst Birgitte, Brandt Erik, Bach Anders et al.

Molecular endocrinology (Baltimore, Md.)

PMID 15905359
MK-6772003
The effect of treatment with the oral growth hormone (GH) secretagogue MK-677 on GH isoforms.

Svensson J, Boguszewski C L, Shibata F et al.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society

PMID 12550076
MK-6772001
Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.

Murphy M G, Weiss S, McClung M et al.

The Journal of clinical endocrinology and metabolism

PMID 11238495
Tirzepatide2025
Effects of Tirzepatide in Type 2 Diabetes: Individual Variation and Relationship to Cardiometabolic Outcomes.

Aminorroaya Arya, Oikonomou Evangelos K, Biswas Dhruva et…

Journal of the American College of Cardiology

PMID 40368575
Tirzepatide2026
Tirzepatide as Adjunct to Insulin in Adults With Type 1 Diabetes and Overweight or Obesity: A Systematic Review of Randomized and Real-World Evidence.

Acucella Giuseppina Alessia, Caponio Danilo

Endocrinology, diabetes & metabolism

PMID 42007544
Tirzepatide2024
Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program.

Nicholls Stephen J, Tofé Santiago, le Roux Carel W et al.

Cardiovascular diabetology

PMID 38341541
Tirzepatide2025
Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis.

Mather Kieren J, Mari Andrea, Weerakkody Govinda et al.

Diabetes, obesity & metabolism

PMID 39762971
Tirzepatide2025
Tirzepatide Treatment and Associated Changes in β-Cell Function and Insulin Sensitivity in People With Obesity or Overweight With Prediabetes or Normoglycemia: A Post Hoc Analysis From the SURMOUNT-1 Trial.

Mari Andrea, Stefanski Adam, van Raalte Daniel H et al.

Diabetes care

PMID 40694530
Tirzepatide2025
Early induction of insulin sensitisation treated by tirzepatide: a prospective, single-arm, open-label study in Japanese individuals with obesity and type 2 diabetes.

Yamaguchi Yuko, Kuwata Hitoshi, Imura Masahiro et al.

Diabetologia

PMID 40694059
Tirzepatide2026
Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial.

Malhotra Atul, Grunstein Ronald, Azarbarzin Ali et al.

Nature medicine

PMID 41540105
Tirzepatide2026
LEAN mass Preservation with Resistance Exercise and Protein during semaglutide and tirzepatide therapy (LEAN-PREP study): a protocol for a randomised controlled trial.

Alawadhi Ameenah A, Alroudhan Dherar, Alsaeed Dalal J et al.

BMJ open

PMID 42020128
Tirzepatide2025
Mediterranean diet adherence and tirzepatide: real-world evidence on adiposity indices and insulin resistance beyond weight loss.

Paternò Valentina, Geraci Giulio, Piticchio Tommaso et al.

Frontiers in endocrinology

PMID 41613958
Tirzepatide2021
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect.

Fisman Enrique Z, Tenenbaum Alexander

Cardiovascular diabetology

PMID 34819089
Tirzepatide2022
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence.

Muzurović Emir M, Volčanšek Špela, Tomšić Karin Zibar et al.

Journal of cardiovascular pharmacology and therapeutics

PMID 36546652
Tirzepatide2026
A metabolic comparison of GIPR agonism versus GIPR antagonism in male mice.

Davies Iona, Turland Alexandra, Tran Hanh Duyen et al.

Diabetes, obesity & metabolism

PMID 41287212
Tirzepatide2026
Effect of Weight-Neutral Treatment With Semaglutide or Tirzepatide on β-Cell Identity in db/db Mice.

Deng Zhaobin, Zheng Dongxu, Son Jinsook et al.

Acta physiologica (Oxford, England)

PMID 41354136
Tirzepatide2025
The role of gut microbiota in Tirzepatide-mediated alleviation of high-fat diet-induced obesity.

Wang Ruonan, Lin Zijing, He Mingjie et al.

European journal of pharmacology

PMID 40516844
Tirzepatide2025
A novel therapeutic prospect: a dual-acting tirzepatide for Alzheimer's disease.

Alshehri Ghadah H, Al-Kuraishy Hayder M, Al-Gareeb Ali I …

European journal of pharmacology

PMID 40706971
Tirzepatide2025
GLP-1-based medications: Mechanisms involved in obesity treatment.

Salvador Javier

Medicina clinica

PMID 40466247
Tirzepatide2026
Real-World Comparison of Short-Term Adverse Events, Treatment Persistence, and Efficacy of Semaglutide and Tirzepatide: A Nationwide Multicenter Study.

Hepşen Sema, Haymana Cem, Ertepe Küçükgöde Gizem et al.

Obesity facts

PMID 42030208
Tirzepatide2026
Persistence-Dependent Effectiveness of Tirzepatide on the Cardio-Metabolic-Kidney Syndrome Outcomes in Obesity: Real-World Evidence from the United Arab Emirates.

Rangraze Imran Rashid, El-Tanani Mohamed, Janez Andrej et…

Diabetes therapy

PMID 42029986
Tirzepatide2026
A novel, widespread impurity in mass-compounded tirzepatide/b12 products: patient safety implications.

Jordan Brad, Arbogast Luke, Clemens Matthew et al.

Expert opinion on drug safety

PMID 42010938
Tirzepatide2026
Drug-Associated Ketoacidosis: A Comprehensive Disproportionality Analysis Based on the FAERS Database.

Du Pengqiang, Chen Xiaoyu, Xu Yinpeng et al.

Diabetes, obesity & metabolism

PMID 42010884
Tirzepatide2026
GLP-1 Receptor Agonist Use and Wound Outcomes After Free Flap Breast Reconstruction.

Ha Joy, Lester Ethan, De May Henning et al.

Journal of reconstructive microsurgery

PMID 42013898
Tirzepatide2026
Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on cardiovascular-kidney-metabolic stage progression: a real-world cohort study.

Wu Jheng-Yan, Lee Keng-Wei, Huang Sheng-Chi et al.

Diabetes research and clinical practice

PMID 42009260
Tirzepatide2026
GLP-1-based therapies and limb outcomes in PAD: a systematic review and meta-analysis of real-world studies.

Boccatonda Andrea, D'Ardes Damiano, Brighenti Alice et al.

Diabetes research and clinical practice

PMID 42009258
Tirzepatide2026
Shifts in body mass index category with tirzepatide and associated changes in cardiometabolic risk factors in people with obesity: a post hoc analysis from the SURMOUNT-1 and SURMOUNT-4 trials.

Sattar Naveed, Lee Clare J, Srinath Reshmi et al.

American journal of preventive cardiology

PMID 42006438
Tirzepatide2025
Tirzepatide for metabolic dysfunction-associated steatohepatitis: results from phase II clinical trials and perspectives.

Fiorucci Stefano, Urbani Ginevra

Expert opinion on investigational drugs

PMID 40782123
Tirzepatide2026
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients with Type 2 Diabetes and Diabetic Retinopathy.

Shah Jui, Makwana Bhargav, Panchal Krisha et al.

American journal of ophthalmology

PMID 42025665
Tirzepatide2026
Rapid remission of Hailey-Hailey disease with tirzepatide therapy: A case report.

Velusamy Breethiga, Sokumbi Olayemi, Latimer Benjamin L e…

JAAD case reports

PMID 42011394
Tirzepatide2026
Integrated Evidence from VigiBase and Clinical Trials: A Comprehensive Pharmacovigilance Analysis of Seven Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs).

Li Jiaxun, Liang Jizhou, Zhang Wei et al.

Diabetes therapy

PMID 42012593
Tesamorelin2026
Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials.

Badran Ahmed Samy, Helal Abdulrhman, Shata Karim Samir et…

Obesity research & clinical practice

PMID 41545261
Tesamorelin2024
Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors.

Russo Samuel C, Ockene Mollie W, Arpante Allison K et al.

AIDS (London, England)

PMID 38905488
Tesamorelin2007
Metabolic effects of a growth hormone-releasing factor in patients with HIV.

Falutz Julian, Allas Soraya, Blot Koenraad et al.

The New England journal of medicine

PMID 18057338
Tesamorelin2012
Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial.

Makimura Hideo, Feldpausch Meghan N, Rope Alison M et al.

The Journal of clinical endocrinology and metabolism

PMID 23015655
Tesamorelin2020
Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD.

Fourman Lindsay T, Billingsley James M, Agyapong George e…

JCI insight

PMID 32701508
Tesamorelin2025
Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity.

Ellis Ronald J, Vaida Florin, Hu Keren et al.

The Journal of infectious diseases

PMID 39813152
Tesamorelin2012
Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.

Baker Laura D, Barsness Suzanne M, Borson Soo et al.

Archives of neurology

PMID 22869065
Tesamorelin2015
Population pharmacokinetic and pharmacodynamic analysis of tesamorelin in HIV-infected patients and healthy subjects.

González-Sales Mario, Barrière Olivier, Tremblay Pierre O…

Journal of pharmacokinetics and pharmacodynamics

PMID 25895899
Tesamorelin2014
The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GH.

Makimura Hideo, Murphy Caitlin A, Feldpausch Meghan N et al.

The Journal of clinical endocrinology and metabolism

PMID 24178787
Tesamorelin2017
Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial.

Clemmons David R, Miller Sam, Mamputu Jean-Claude

PloS one

PMID 28617838
Tesamorelin2023
Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial.

Rahman Farah, McLaughlin Taryn, Mesquita Pedro et al.

Journal of clinical and translational science

PMID 36845310
Tesamorelin2011
Relationship of adiponectin to endogenous GH pulse secretion parameters in response to stimulation with a growth hormone releasing factor.

Makimura H, Stanley T L, Chen C Y et al.

Growth hormone & IGF research

PMID 21531600
Tesamorelin2017
Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation.

Braun Laurie R, Feldpausch Meghan N, Czerwonka Natalia et…

Growth hormone & IGF research

PMID 29031905
Tesamorelin2011
Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men.

Stanley Takara L, Chen Cindy Y, Branch Karen L et al.

The Journal of clinical endocrinology and metabolism

PMID 20943777
Tesamorelin2026
Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.

Uçaktürk Ebru, Nemutlu Emirhan

Journal of pharmaceutical and biomedical analysis

PMID 41138283
Tesamorelin2023
Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.

Cristea Cătălina-Diana, Radu Mihai, Toboc Ani et al.

Analytical biochemistry

PMID 37806509
Tesamorelin2022
An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.

Coppieters Gilles, Deventer Koen, Polet Michaël et al.

Journal of pharmaceutical and biomedical analysis

PMID 35298973
Tesamorelin2025
Carpal Tunnel Syndrome Attributed to Medication Use: A Pharmacovigilance Study.

Mihalache Andrew, Volfson Emily, Huang Ryan et al.

Cureus

PMID 40510111
Tesamorelin2025
Metabolic dysfunction-associated steatotic liver disease in people with HIV.

Gattu Arijeet K, Fourman Lindsay T

Current opinion in HIV and AIDS

PMID 40397552
Ipamorelin1998
Ipamorelin, the first selective growth hormone secretagogue.

Raun K, Hansen B S, Johansen N L et al.

European Journal of Endocrinology

PMID 9849822
Ipamorelin1999
Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.

Gobburu J V, Agersø H, Jusko W J et al.

Pharmaceutical Research

PMID 10496658
Ipamorelin2014
Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.

Beck David E, Sweeney W Brian, McCarter Martin D et al.

International Journal of Colorectal Disease

PMID 25331030
Ipamorelin2020
Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics.

N Mohammadi Ehsan, Louwies Tijs, Pietra Claudio et al.

Journal of Experimental Pharmacology

PMID 32801950
Ipamorelin2024
The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.

Lu Zengbing, Ngan Man P, Liu Julia Y H et al.

Physiology & Behavior

PMID 39043357
Ipamorelin2001
Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues.

Lall S, Tung L Y, Ohlsson C et al.

Biochemical and Biophysical Research Communications

PMID 11162489
Ipamorelin2003
Growth hormone (GH) hypersecretion and GH receptor resistance in streptozotocin diabetic mice in response to a GH secretagogue.

Johansen Peter B, Segev Yael, Landau Daniel et al.

Experimental Diabesity Research

PMID 14630569
Ipamorelin2002
Influence of chronic treatment with the growth hormone secretagogue Ipamorelin, in young female rats: somatotroph response in vitro.

Jiménez-Reina L, Cañete R, de la Torre M J et al.

Histology and Histopathology

PMID 12168778
Ipamorelin2019
Glycine-modified growth hormone secretagogues identified in seized doping material.

Gajda Paulina Marta, Holm Niels Bjerre, Hoej Lars Jakobse…

Drug Testing and Analysis

PMID 30136411
Ipamorelin2015
Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin.

Semenistaya Ekaterina, Zvereva Irina, Thomas Andreas et al.

Drug Testing and Analysis

PMID 25869809
Ipamorelin2026
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.

Coutinho Luis F D, DE Oliveira Neves Lucas F, Camilo Rafa…

The Journal of Sports Medicine and Physical Fitness

PMID 41880199
Ipamorelin1999
Pharmacological characterisation of a new oral GH secretagogue, NN703.

Hansen B S, Raun K, Nielsen K K et al.

European Journal of Endocrinology

PMID 10427162
Ipamorelin2018
Analysis of new growth promoting black market products.

Krug Oliver, Thomas Andreas, Malerød-Fjeld Helle et al.

Growth Hormone & IGF Research

PMID 29864719
Ipamorelin2024
The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus.

Gouda Mallikarjun, Ganesh C B

Animal Reproduction Science

PMID 38996787
Phase 1–2 / PreclinicalEarly-phase human trials and well-replicated animal studies.29 sources
Thymosin Alpha-12026
IL-15 Plus Thymosin α1 Reduces Senescent Hepatic CD8+ T Cells in Hepatocellular Carcinoma via PI3K/AKT Suppression.

Wu Fengtian, Guo Zixuan, Guan Jun et al.

Journal of Gastroenterology and Hepatology

PMID 41883056
Thymosin Alpha-12026
A Case Report of a Multisystemic Immune-Related Adverse Event Caused by Sintilimab in Combination With Thymosin Alpha-1.

Li Ting, Wu Bao-Liang, Yu Cai-Long et al.

Clinical Case Reports

PMID 41669704
Thymosin Alpha-12026
Zerumbone mediated CD1d inhibition suppresses epithelial to mesenchymal transition in triple negative breast cancer.

Shyanti Ritis Kumar, Sharma Sudhanshu, Haque Mazharul et al.

Discover Oncology

PMID 41511636
Thymosin Alpha-12025
Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis.

Tian Yong, Yao Jiaqi, Ma Yihan et al.

Frontiers in Immunology

PMID 40599771
Thymosin Alpha-12025
Effect of thymosin α1 on Immune response and organ function in acute aortic dissection surgery: PANDA II trial protocol.

Liu Hong, Qian Si-Chong, Zhang Ying-Yuan et al.

Future Cardiology

PMID 40367062
Thymosin Alpha-12025
The efficacy and safety of thymosin alpha-1 combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a retrospective study.

Yao Siyang, Huang Qiangsong, Zou Yan et al.

Scientific Reports

PMID 40263352
Thymosin Alpha-12025
Exploiting the potential of in situ forming liquid crystals: development and in vitro performance of long-acting depots for peptide drug thymosin alpha 1 subcutaneous administration.

Vitek Mercedes, Zvonar Pobirk Alenka, Roškar Robert et al.

Drug Delivery

PMID 40066714
Thymosin Alpha-12024
Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.

Cao Ailing, Feng Fanchao, Zhou Xianmei

Journal of the College of Physicians and Surgeons — Pakistan

PMID 39648386
Thymosin Alpha-12024
Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy.

Liu Kua, Kong Lingkai, Cui Huawei et al.

Cell Reports Medicine

PMID 39357524
Thymosin Alpha-12024
Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1 in Human Clinical Trials.

Dinetz Elliot, Lee Edwin

Alternative Therapies in Health and Medicine

PMID 38308608
Thymosin Alpha-12023
Immune modulation via dendritic cells by the effect of Thymosin-alpha-1 on immune synapse in HCMV infection.

Espinar-Buitrago M S, Vazquez-Alejo E, Magro-Lopez E et al.

International Immunopharmacology

PMID 38149577
Thymosin Alpha-12024
Enhanced Immunomodulatory Effects of Thymosin-Alpha-1 in Combination with Polyanionic Carbosilane Dendrimers against HCMV Infection.

Espinar-Buitrago María de la Sierra, Magro-López Esmerald…

International Journal of Molecular Sciences

PMID 38396631
Thymosin Alpha-12024
Immune-Enhancing Treatment among Acute Necrotizing Pancreatitis Patients with Metabolic Abnormalities: A Post Hoc Analysis of a Randomized Clinical Trial.

Huang Xiaofei, Mao Wenjian, Hu Xingxing et al.

Gut and Liver

PMID 38356344
Thymosin Alpha-12023
Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model.

Ricci Daniela, Etna Marilena Paola, Severa Martina et al.

International Immunopharmacology

PMID 36933449
Thymosin Alpha-12016
Immune Modulation with Thymosin Alpha 1 Treatment.

King R, Tuthill C

Vitamins and Hormones

PMID 27450734
Thymosin Alpha-12016
Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection.

Al-Mahtab Mamun, Bazinet Michel, Vaillant Andrew

PLoS One

PMID 27257978
Thymosin Alpha-12016
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases.

Pica F, Chimenti M S, Gaziano R et al.

Clinical and Experimental Immunology

PMID 27350088
Thymosin Alpha-12015
Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation.

Binsfeld Marilène, Hannon Muriel, Otjacques Eléonore et al.

Cancer Immunology, Immunotherapy

PMID 25971542
Thymosin Alpha-12018
Cellular proteostasis: a new twist in the action of thymosin α1.

Stincardini Claudia, Renga Giorgia, Villella Valeria et al.

Expert Opinion on Biological Therapy

PMID 30063867
Thymosin Alpha-12018
Thymosin Alpha1-Fc Modulates the Immune System and Down-regulates the Progression of Melanoma and Breast Cancer with a Prolonged Half-life.

Wang Fanwen, Yu Tingting, Zheng Heng et al.

Scientific Reports

PMID 30120362
Thymosin Alpha-12017
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.

Romani Luigina, Oikonomou Vasilis, Moretti Silvia et al.

Nature Medicine

PMID 28394330
Thymosin Alpha-12020
Immunopotentiator thymosin alpha-1 attenuates inflammatory pain by modulating the Wnt3a/β-catenin pathway in spinal cord.

Huang Jiahua, Jiang Huaqing, Pan Meijun et al.

Neuroreport

PMID 31764244
Thymosin Alpha-12019
Thymosin Alpha-1 Inhibits Complete Freund's Adjuvant-Induced Pain and Production of Microglia-Mediated Pro-inflammatory Cytokines in Spinal Cord.

Xu Yunlong, Jiang Yanjun, Wang Lin et al.

Neuroscience Bulletin

PMID 30790216
Thymosin Alpha-11999
Evidence that endogenous thymosin alpha-1 is present in the rat central nervous system.

Turrini P, Aloe L

Neurochemistry International

PMID 10524714
Thymosin Alpha-11998
High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma.

Pica F, Fraschetti M, Matteucci C et al.

Anticancer Research

PMID 9858941
Thymosin Alpha-11996
Psychological disturbance alters thymic and adrenal hormone secretion in a parallel but independent manner.

Coe C L, Hall N R

Psychoneuroendocrinology

PMID 8774065
Thymosin Alpha-11994
Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats.

Rasi G, Silecchia G, Sinibaldi-Vallebona P et al.

International Journal of Cancer

PMID 8194879
Thymosin Alpha-11994
Combined effect of fluconazole and thymosin alpha 1 on systemic candidiasis in mice immunosuppressed by morphine treatments.

di Francesco P, Gaziano R, Casalinuovo I A et al.

Clinical and Experimental Immunology

PMID 8082290
Thymosin Alpha-11994
[Thymosin alpha-1 and hybrid proteins consisting of tumor necrosis factor-alpha and thymosin alpha-1 enhance the efficacy of vaccination against the causative agent of plague].

Shmelev V A, Grigor'ev B V, Mozharova T I et al.

Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii

PMID 7992547
ObservationalRetrospective studies and cohort data.219 sources
BPC-1572013
Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy.

Cesarec Vedran, Becejac Tomislav, Misic Marija et al.

European journal of pharmacology

PMID 23220707
BPC-1572026
From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management.

Yuan Claire, Demers Ariana, Silva-Ortiz Victor et al.

International journal of molecular sciences

PMID 41898733
BPC-1572025
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.

Lee Edwin, Burgess Kailynd

Alternative therapies in health and medicine

PMID 40131143
BPC-1572025
Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.

Sikiric Predrag, Seiwerth Sven, Skrtic Anita et al.

Pharmaceuticals (Basel, Switzerland)

PMID 40573323
BPC-1572014
BPC 157 and blood vessels.

Seiwerth Sven, Brcic Luka, Vuletic Lovorka Batelja et al.

Current pharmaceutical design

PMID 23782145
BPC-1572014
Stable gastric pentadecapeptide BPC 157-NO-system relation.

Sikiric Predrag, Seiwerth Sven, Rucman Rudolf et al.

Current pharmaceutical design

PMID 23755725
BPC-1572026
Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics.

Sikiric Predrag, Barisic Ivan, Udovicic Mario et al.

Pharmaceuticals (Basel, Switzerland)

PMID 41901308
BPC-1572014
Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts.

Chang Chung-Hsun, Tsai Wen-Chung, Hsu Ya-Hui et al.

Molecules (Basel, Switzerland)

PMID 25415472
BPC-1572019
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.

Gwyer Daniel, Wragg Nicholas M, Wilson Samantha L

Cell and tissue research

PMID 30915550
BPC-1572018
Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine.

Drmic Domagoj, Samara Mariam, Vidovic Tinka et al.

World journal of gastroenterology

PMID 30622376
BPC-1572016
Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short-Bowel Rats.

Lojo Nermin, Rasic Zarko, Zenko Sever Anita et al.

PloS one

PMID 27627764
BPC-1572016
Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula.

Grgic Tihomir, Grgic Dora, Drmic Domagoj et al.

European journal of pharmacology

PMID 26875638
BPC-1572016
Stable gastric pentadecapeptide BPC 157 heals rectovaginal fistula in rats.

Baric Marko, Sever Anita Zenko, Vuletic Lovorka Batelja e…

Life sciences

PMID 26872976
BPC-1572015
Duodenocutaneous fistula in rats as a model for 'wound healing-therapy' in ulcer healing: the effect of pentadecapeptide BPC 157, L-nitro-arginine methyl ester and L-arginine.

Skorjanec S, Kokot A, Drmic D et al.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society

PMID 26348082
BPC-1572015
Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro.

Huang Tonglie, Zhang Kuo, Sun Lijuan et al.

Drug design, development and therapy

PMID 25995620
BPC-1572015
Perforating corneal injury in rat and pentadecapeptide BPC 157.

Masnec Sanja, Kokot Antonio, Zlatar Mirna et al.

Experimental eye research

PMID 25912999
BPC-1572019
Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats.

Perovic Darko, Kolenc Danijela, Bilic Vide et al.

Journal of orthopaedic surgery and research

PMID 31266512
BPC-1572012
Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin.

Stupnisek Mirjana, Franjic Sandra, Drmic Domagoj et al.

Thrombosis research

PMID 21840572
BPC-1572025
BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions.

Sikiric Predrag, Seiwerth Sven, Skrtic Anita et al.

Pharmaceuticals (Basel, Switzerland)

PMID 41155565
BPC-1572026
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review.

Matek Danijel, Matek Irena, Japjec Mladen et al.

Pharmaceuticals (Basel, Switzerland)

PMID 41754849
BPC-1572016
Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME.

Djakovic Zeljko, Djakovic Ivka, Cesarec Vedran et al.

World journal of gastroenterology

PMID 27895400
BPC-1572026
Fourier Transform Infrared Spectroscopic Characterization of Aortic Wall Remodeling by Stable Gastric Pentadecapeptide BPC 157 After Unilateral Adrenalectomy in Rats.

Smoday Ivan Maria, Vukovic Vlasta, Oroz Katarina et al.

Pharmaceuticals (Basel, Switzerland)

PMID 41599787
BPC-1572026
Tracheocutaneous Fistula Resolved by Pentadecapeptide BPC 157 Therapy Through the NO-System-Triple NO-Agent Approach in Rats.

Madzarac Goran, Becejac Tomislav, Penovic Toni et al.

Pharmaceuticals (Basel, Switzerland)

PMID 41599743
BPC-1572025
Acute Compartment Syndrome and Intra-Abdominal Hypertension, Decompression, Current Pharmacotherapy, and Stable Gastric Pentadecapeptide BPC 157 Solution.

Sikiric Predrag, Seiwerth Sven, Skrtic Anita et al.

Pharmaceuticals (Basel, Switzerland)

PMID 40573261
BPC-1572026
Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias.

Sikiric Predrag, Barisic Ivan, Udovicic Mario et al.

Pharmaceuticals (Basel, Switzerland)

PMID 41754776
BPC-1572026
Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats.

Grubisic Marija Medvidovic, Strbe Sanja, Barisic Ivan et al.

Current neuropharmacology

PMID 41832718
BPC-1572013
Salutary effect of gastric pentadecapeptide BPC 157 in two different stress urinary incontinence models in female rats.

Jandric Ivan, Vrcic Hrvoje, Jandric Balen Marica et al.

Medical science monitor basic research

PMID 23478678
TB-5002026

Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.

Mavrych Volodymyr, Shypilova Inna, Bolgova Olena

Frontiers in aging

PMID 42021992
TB-5002026

Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

Mendias Christopher L, Awan Tariq M

Sports medicine (Auckland, N.Z.)

PMID 41966639
TB-5002026

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

Rahman Omar F, Lee Steven J, Seeds William A

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews

PMID 41490200
TB-5002026

Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.

Mayfield Cory K, Bolia Ioanna K, Feingold Cailan L et al.

The American journal of sports medicine

PMID 41476424
TB-5002025

Comparative effects of dietary sodium butyrate and tributyrin on broiler chickens' performance, gene expression, intestinal histomorphometry, blood indices, and litter.

Ismael Elshaimaa, Kamel Shaimaa, Elleithy Ebtihal M M et al.

Scientific reports

PMID 40681595
TB-5002024

Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro.

Rahaman Khandoker Asiqur, Muresan Anca Raluca, Min Hophil…

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

PMID 38382158
TB-5002017

Adsorption effects of the doping relevant peptides Insulin Lispro, Synachten, TB-500 and GHRP 5.

Judák Péter, Van Eenoo Peter, Deventer Koen

Analytical biochemistry

PMID 28887173
TB-5002016

Comparison of various in vitro model systems of the metabolism of synthetic doping peptides: Proteolytic enzymes, human blood serum, liver and kidney microsomes and liver S9 fraction.

Zvereva Irina, Semenistaya Ekaterina, Krotov Grigory et al.

Journal of proteomics

PMID 27569051
TB-5002016

Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.

Thomas Andreas, Görgens Christian, Guddat Sven et al.

Journal of separation science

PMID 26578461
TB-5002016

Solid-phase extraction of small biologically active peptides on cartridges and microelution 96-well plates from human urine.

Semenistaya Ekaterina, Zvereva Irina, Krotov Grigory et al.

Drug testing and analysis

PMID 26472487
TB-5002015

In vitro models for metabolic studies of small peptide hormones in sport drug testing.

Esposito Simone, Deventer Koen, Geldof Lore et al.

Journal of peptide science : an official publication of the European Peptide Society

PMID 25469748
TB-5002014

Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions.

Thevis Mario, Thomas Andreas, Schänzer Wilhelm

Expert review of proteomics

PMID 25382550
TB-5002014

Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls.

Thevis Mario, Schänzer Wilhelm

Journal of pharmaceutical and biomedical analysis

PMID 24906629
TB-5002013

Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.

Kwok Wai Him, Ho Emmie N M, Lau Ming Yip et al.

Analytical and bioanalytical chemistry

PMID 23318763
TB-5002012

Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry.

Ho Emmie N M, Kwok W H, Lau M Y et al.

Journal of chromatography. A

PMID 23084823
TB-5002012

Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential.

Esposito Simone, Deventer Koen, Goeman Jan et al.

Drug testing and analysis

PMID 22962027
Epitalon2026

Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.

Mavrych Volodymyr, Shypilova Inna, Bolgova Olena

Frontiers in aging

PMID 42021992
Epitalon2025

Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity.

Al-Dulaimi Sarah, Thomas Ross, Matta Sheila et al.

Biogerontology

PMID 40908429
Epitalon2025

The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy.

Gatta Marco, Dovizio Melania, Milillo Cristina et al.

Stem cell reviews and reports

PMID 40493162
Epitalon2025

Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties.

Araj Szymon Kamil, Brzezik Jakub, Mądra-Gackowska Katarzy…

International journal of molecular sciences

PMID 40141333
Epitalon2025

Epitalon-activated telomerase enhance bovine oocyte maturation rate and post-thawed embryo development.

Ullah Safeer, Haider Zaheer, Perera Chalani Dilshani et al.

Life sciences

PMID 39788414
Epitalon2023

EPIGENETIC MODIFICATION UNDER THE INFLUENCE OF PEPTIDE BIOREGULATORS ON THE 'OLD' CHROMATIN.

Lezhava T, Jokhadze T, Monaselidze J et al.

Georgian medical news

PMID 37042594
Epitalon2022

Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro.

Yue Xue, Liu Sai-Li, Guo Jia-Ni et al.

Aging

PMID 35413689
Epitalon2022

Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line.

Avolio Francesco, Martinotti Stefano, Khavinson Vladimir …

International journal of molecular sciences

PMID 35408963
Epitalon2020

[The influence of AEDG and KE peptides on mitochondries stain and L7A ribosomes protein expression during human pineal gland and thymus cell senescence in vitro.]

Ivko O M, Drobintseva A O, Leont'eva D O et al.

Advances in gerontology = Uspekhi gerontologii

PMID 33342107
Epitalon2020

AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism.

Khavinson Vladimir, Diomede Francesca, Mironova Ekaterina…

Molecules (Basel, Switzerland)

PMID 32019204
Epitalon2017

Short Exogenous Peptides Regulate Expression of CLE, KNOX1, and GRF Family Genes in Nicotiana tabacum.

Fedoreyeva L I, Dilovarova T A, Ashapkin V V et al.

Biochemistry. Biokhimiia

PMID 28371610
Epitalon2014

[Main mechanisms of rhabdomyolysis-caused kidney injury and their correction by organospecific peptides].

Zamorskij I I, Shchudrova T S

Biofizika

PMID 25730989
Epitalon2014

[Peptides and CCL11 and HMGB1 as molecular markers of aging: literature review and own data].

Khavinson V Kh, Kuznik B I, Tarnovskaia S I et al.

Advances in gerontology = Uspekhi gerontologii

PMID 25826983
Epitalon2012

Melatonin and pineal gland peptides are able to correct the impairment of reproductive cycles in rats.

Arutjunyan Alexander, Kozina Ljudmila, Milyutina Yulia et…

Current aging science

PMID 23237594
Epitalon2011

[Characteristics of the pineal gland and thymus relationship in aging].

Lin'kova N S, Poliakova V O, Kvetnoi I M et al.

Advances in gerontology = Uspekhi gerontologii

PMID 21809618
Epitalon2010

[Influence of peptides from pineal gland on thymus function at aging].

Lin'kova N S, Poliakova V O, Trofimov A V et al.

Advances in gerontology = Uspekhi gerontologii

PMID 21510076
Epitalon2009

[Effect of preparations melatonin and epitalon on the age-related dynamics of thyrotrophic activity of the hypophysis and thyroid gland function in different light regimes].

Vinogradova I A

Advances in gerontology = Uspekhi gerontologii

PMID 20405731
Epitalon2007

[The effect of pineal peptide preparations on proliferative activity in organotypic culture of the preoptic hypothalamus area].

Miliutina Iu P, Kozina L S, Arutiunian A V et al.

Advances in gerontology = Uspekhi gerontologii

PMID 18383712
Epitalon2007

[Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly people].

Korkushko O V, Lapin B A, Goncharova N D et al.

Advances in gerontology = Uspekhi gerontologii

PMID 17969590
Epitalon2007

[Age-related changes of exercise capacity and some biochemical indices of rat muscles under influence of different light conditions and pineal preparations].

Vingradova I A, Iliukha V A, Fedorova A S et al.

Advances in gerontology = Uspekhi gerontologii

PMID 17969589
Epitalon2006

[Comparative study of the effects of melatonin and epitalon on the protracted memory under the shuttle labyrinth test conditions in rats in the course of aging].

Vinogradova I A

Eksperimental'naia i klinicheskaia farmakologiia

PMID 17209456
Epitalon2006

[Effect of age, different light conditions, melatonin, and epitalon on lysosomal proteinase activity in the liver and kidneys of rats].

Rendakov N L, Tiutiunnik N N, Vinogradova I A

Advances in gerontology = Uspekhi gerontologii

PMID 17152724
Epitalon2006

[Influence of light regimens, melatonin, and epitalon on amylase activity in the pancreas and small intestine in rats of different age].

Svechkina E B, Tiutiunnik N N, Vinogradova I A

Advances in gerontology = Uspekhi gerontologii

PMID 17152723
Epitalon2006

Anti-aging peptide bioregulators induce reactivation of chromatin.

Lezhava T, Monaselidze J, Kadotani T et al.

Georgian medical news

PMID 16705247
Epitalon2005

[Effect of epitalon and melatonin on life span and spontaneous carcinogenesis in senescence accelerated mice (SAM)].

Anisimov V N, Popovich I G, Zabezhinskij M A et al.

Voprosy onkologii

PMID 15909815
Epitalon2005

Pineal peptides restore the age-related disturbances in hormonal functions of the pineal gland and the pancreas.

Goncharova N D, Vengerin A A, Khavinson V Kh et al.

Experimental gerontology

PMID 15664732
Epitalon2004

Stressors and antistressors: how do they influence life span in HER-2/neu transgenic mice?

Semenchenko Ganna V, Anisimov Vladimir N, Yashin Anatoli I

Experimental gerontology

PMID 15501020
Epitalon2004

[Effect of epitalon on the immunity and hemostasis in hypophysectomized chicken and old hens].

Kuznik B I, Pateiuk A V, Khavinson V Kh et al.

Advances in gerontology = Uspekhi gerontologii

PMID 15490730
Epitalon2000

Effect of epitalon on the lifespan increase in Drosophila melanogaster.

Khavinson V K, Izmaylov D M, Obukhova L K et al.

Mechanisms of ageing and development

PMID 11087911
GHK-Cu2026

Glycyl-L-histidyl-L-lysine-Cu2+ (GHK-Cu) Attenuates CuSO4 or LPS induced-inflammation in Zebrafish larvae model.

Hu Jing, Zhang Chao, Wang Feifei

European journal of pharmacology

PMID 41997403
GHK-Cu2026

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

Rahman Omar F, Lee Steven J, Seeds William A

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews

PMID 41490200
GHK-Cu2025

Copper Complexes with New Glycyl-l-histidyl-l-lysine-Hyaluronan Conjugates Show Antioxidant Properties and Osteogenic and Angiogenic Synergistic Effects.

Greco Valentina, Lanza Valeria, Tomasello Barbara et al.

Bioconjugate chemistry

PMID 40123442
GHK-Cu2025

An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-Inflammatory and antioxidant.

Hu Die, Zhang Xuexun, Gong Shiwen et al.

Colloids and surfaces. B, Biointerfaces

PMID 40716276
GHK-Cu2024

The glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6.

Bian Yiding, Deng Mingming, Liu Jia et al.

Redox biology

PMID 38879894
GHK-Cu2024

Behavioral and neuropathological features of Alzheimer's disease are attenuated in 5xFAD mice treated with intranasal GHK peptide.

Tucker Matthew, Liao Gerald Yu, Keely Addison et al.

Aging pathobiology and therapeutics

PMID 40766919
GHK-Cu2025

Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.

Mortazavi Seyedeh Maryam, Mohammadi Vadoud Seyyed Ali, Mo…

BioImpacts : BI

PMID 39963574
GHK-Cu2025

Palmitoyl copper peptide and acetyl tyrosine complex enhances melanin production in both A375 and B16 cell lines.

Hong Minhua, Gui Yingyue, Xu Jiayao et al.

Biochemical and biophysical research communications

PMID 39632290
GHK-Cu2024

Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application.

Liu Tianqi, Liu Ying, Zhao Xiaoyu et al.

Bioactive materials

PMID 38026438
GHK-Cu2026

Golgi-targeted copper delivery strategy via enhancing copper-dependent proteins' activity for fascia regeneration.

Wang Rui, Xu Yiru, Saiding Qimanguli et al.

Journal of controlled release : official journal of the Controlled Release Society

PMID 41371501
GHK-Cu2025

Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms.

Mao Shuzhen, Huang Jiahui, Li Junyan et al.

Frontiers in pharmacology

PMID 40672369
GHK-Cu2025

Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?

Ogórek Karolina, Nowak Kinga, Wadych Emilia et al.

Molecules (Basel, Switzerland)

PMID 39795193
Selank2018
Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity

Vyunova Tatiana V, Andreeva Lioudmila, Shevchenko Konstan…

Protein and peptide letters

PMID 30255741
Selank2017
Tuftsin - Properties and Analogs

Siebert Agnieszka, Gensicka-Kowalewska Monika, Cholewinsk…

Current medicinal chemistry

PMID 28745220
Selank2022
Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats

Konstantinopolsky M A, Chernyakova I V, Kolik L G

Bulletin of experimental biology and medicine

PMID 36322304
Selank2020
Functional Connectomic Approach to Studying Selank and Semax Effects

Panikratova Ya R, Lebedeva I S, Sokolov O Yu et al.

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections

PMID 32342318
Selank2017
Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats

Kasian Anastasiya, Kolomin Timur, Andreeva Lyudmila et al.

Behavioural neurology

PMID 28280289
Selank2017
Effect of Selank on Spontaneous Synaptic Activity of Rat Hippocampal CA1 Neurons

Povarov I S, Kondratenko R V, Derevyagin V I et al.

Bulletin of experimental biology and medicine

PMID 28361410
Selank2017
GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells

Filatova Elena, Kasian Anastasiya, Kolomin Timur et al.

Frontiers in pharmacology

PMID 28293190
Selank2017
Anticoagulant Effects of Arginine-Containing Peptides of the Glyproline Family (His-Phe-Arg-Trp-Pro-Gly-Pro and Thr-Lys-Pro-Arg-Pro-Gly-Pro) Revealed by Thromboelastography

Rogozinskaya E Ya, Lyapina M G

Bulletin of experimental biology and medicine

PMID 29181670
Selank2017
Studying the Toxic Effects of Some Biologically Active Peptides on the Model of Mouse Embryonic Stem Cells

Kobylyanskii A G, Zolotarev Yu A, Andreeva L A et al.

Bulletin of experimental biology and medicine

PMID 29063333
Selank2020
Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank

Mukhina A Yu, Mishina E S, Bobyntsev I I et al.

Bulletin of experimental biology and medicine

PMID 32651826
Selank2019
Effect of Selank on Morphological Parameters of Rat Liver in Chronic Foot-Shock Stress

Fomenko E V, Bobyntsev I I, Ivanov A V et al.

Bulletin of experimental biology and medicine

PMID 31243679
Selank2017
Effect of Selank on Functional State of Rat Hepatocytes under Conditions of Restraint Stress

Fomenko E V, Bobyntsev I I, Kryukov A A et al.

Bulletin of experimental biology and medicine

PMID 28853100
Selank2019
State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank Treatment

Mukhina A Yu, Medvedeva O A, Svishcheva M V et al.

Bulletin of experimental biology and medicine

PMID 31236882
Selank2021
The Influence of Selank on the Level of Cytokines Under the Conditions of 'Social' Stress

Leonidovna Yasenyavskaya A, Aleksandrovna Samotrueva M, A…

Current reviews in clinical and experimental pharmacology

PMID 32621722
Selank2019
Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats

Kolik L G, Nadorova A V, Antipova T A et al.

Bulletin of experimental biology and medicine

PMID 31625062
Selank2016
Selank Inhibits Ethanol-Induced Hyperlocomotion and Manifestation of Behavioral Sensitization in DBA/2 Mice

Kolik L G, Nadorova A V, Seredenin S B

Bulletin of experimental biology and medicine

PMID 27878720
Selank2020
The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind

Vanhee Celine, Francotte Antoine, Janvier Steven et al.

Drug testing and analysis

PMID 31667971
Selank2021
Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank

Doyno Cassandra R, White C Michael

Journal of clinical pharmacology

PMID 34396551
Selank2017
Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism

Slominsky P A, Shadrina M I, Kolomin T A et al.

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections

PMID 28702721
Hexarelin2026
Hexarelin promotes the survival of retinal ganglion cells after optic nerve transection.

Chow Kevin Bing Shui

Indian journal of pharmacology

PMID 41766237
Hexarelin2025
Identification of alexamorelin consumption biomarkers using human hepatocyte incubations and high-resolution mass spectrometry.

Pobee Elizabeth, Daziani Gloria, Gameli Prince S et al.

Journal of analytical toxicology

PMID 40465419
Hexarelin2023
Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway.

Guan Chen, Li Chenyu, Shen Xuefei et al.

European journal of medical research

PMID 37710348
Hexarelin2023
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein.

Meanti Ramona, Licata Martina, Rizzi Laura et al.

International journal of molecular sciences

PMID 36674509
Hexarelin2021
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury.

Zambelli Vanessa, Rizzi Laura, Delvecchio Paolo et al.

Drug target insights

PMID 34871336
Hexarelin2022
Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation.

Jiang Bo, Wang Mo, Li Xue et al.

Microvascular research

PMID 34856183
Hexarelin2023
Revealing the interaction between peptide drugs and permeation enhancers in the presence of intestinal bile salts.

Hossain Shakhawath, Kneiszl Rosita, Larsson Per

Nanoscale

PMID 37982184
Hexarelin2021
Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats.

Dahlgren David, Olander Tobias, Sjöblom Markus et al.

Acta pharmaceutica Sinica. B

PMID 34221875
Hexarelin2020
The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin.

Dahlgren David, Sjöblom Markus, Hedeland Mikael et al.

Pharmaceutics

PMID 31991924
Hexarelin2021
Hexarelin Modulation of MAPK and PI3K/Akt Pathways in Neuro-2A Cells Inhibits Hydrogen Peroxide-Induced Apoptotic Toxicity.

Meanti Ramona, Rizzi Laura, Bresciani Elena et al.

Pharmaceuticals (Basel, Switzerland)

PMID 34066741
Hexarelin2021
Stimulation of endogenous pulsatile growth hormone secretion by activation of growth hormone secretagogue receptor reduces the fat accumulation and improves the insulin sensitivity in obese mice.

Huang Zhengxiang, Lu Xuehan, Huang Lili et al.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

PMID 33368660
Hexarelin2021
Ghrelin receptor agonist hexarelin attenuates antinociceptive tolerance to morphine in rats.

Baser Tayfun, Ozdemir Ercan, Filiz Ahmet Kemal et al.

Canadian journal of physiology and pharmacology

PMID 32893668
Hexarelin2020
Hexarelin targets neuroinflammatory pathways to preserve cardiac morphology and function in a mouse model of myocardial ischemia-reperfusion.

McDonald H, Peart J, Kurniawan N D et al.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

PMID 32403043
Hexarelin2019
Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy via the regulation of autophagy.

Agbo E, Li M-X, Wang Y-Q et al.

Die Pharmazie

PMID 31526442
Hexarelin2019
Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE -/- mice.

Cheng Xiu-Li, Ding Fan, Wang De-Ping et al.

Peptides

PMID 31386895
Hexarelin2019
Modulation of PTEN by hexarelin attenuates coronary artery ligation-induced heart failure in rats.

Agbo Elvis, Liu Donhai, Li Meixiu et al.

Turkish journal of medical sciences

PMID 31091855
KPV2026
NLRP3 autophagic degradation disruption in melanocytes contributes to vitiligo development.

Zeng Ke, Zhu Yuqi, Han Zhongxin et al.

Cell death and differentiation

PMID 40935835
KPV2025
Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway.

Sung Junghee, Ju Seo-Young, Park SeungHyun et al.

Tissue & cell

PMID 40073467
KPV2021
Self-Cross-Linked Hydrogel of Cysteamine-Grafted γ-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Rats.

Sun Jie, Xue Pengpeng, Liu Jiayi et al.

ACS biomaterials science & engineering

PMID 34547895
KPV2026
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.

Coutinho Luis F D, DE Oliveira Neves Lucas F, Camilo Rafa…

The Journal of sports medicine and physical fitness

PMID 41880199
KPV2026
Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers.

Cheng Juan, Wu Peng, Li Chenwen et al.

Science advances

PMID 41533788
KPV2025
Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease.

Rodrigues Júlia Morales, Ferreira Leal Ana Paula, Buccini…

Drug discovery today

PMID 41241376
KPV2025
Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review.

Adnan Siti Balqis, Maarof Manira, Fauzi Mh Busra et al.

International journal of medical sciences

PMID 41209547
KPV2024
KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy.

Zhang Li, Li Dongze, Aierken Yierpani et al.

Advanced healthcare materials

PMID 39252648
KPV2024
PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of acute and chronic DSS-induced Colitis.

Zhang Daifang, Jiang Longqi, Yu Fengxu et al.

Frontiers in pharmacology

PMID 39211778
KPV2024
Growth Factors-Loaded Temperature-Sensitive Hydrogel as Biomimetic Mucus Attenuated Murine Ulcerative Colitis via Repairing the Mucosal Barriers.

Li Dingwei, Shangguan Jianxun, Yu Fengnan et al.

ACS applied materials & interfaces

PMID 38289234
KPV2024
A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment.

Marotti Valentina, Xu Yining, Bohns Michalowski Cécilia e…

Bioactive materials

PMID 37859689
KPV2022
A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon.

Zhao Yingzheng, Xue Pengpeng, Lin Gaolong et al.

Acta biomaterialia

PMID 35245681
KPV2022
Skin-adaptive film dressing with smart-release of growth factors accelerated diabetic wound healing.

Zhao Yingzheng, Huang Lantian, Lin Gaolong et al.

International journal of biological macromolecules

PMID 36240893
KPV2021
In situ mucoadhesive hydrogel capturing tripeptide KPV: the anti-inflammatory, antibacterial and repairing effect on chemotherapy-induced oral mucositis.

Shao Weifeng, Chen Rui, Lin Gaolong et al.

Biomaterials science

PMID 34846053
KPV2021
Biomimetic Melanosomes Promote Orientation-Selective Delivery and Melanocyte Pigmentation in the H2O2-Induced Vitiligo Mouse Model.

Sun Ming-Chen, Xu Xiao-Ling, Du Yan et al.

ACS nano

PMID 34662120
Semax2025
Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice.

Liu Rongjie, Chen Yituo, Huang Haosheng et al.

British journal of pharmacology

PMID 40692165
Semax2023
Effect of ACTH4-10Pro8-Gly9-Pro10 on anti-inflammatory cytokine (IL-4, IL-10, IL-13) expression in acute spinal cord injury models (male Sprague Dawley rats).

Asadullah Asadullah, Bajamal Abdul Hafid, Parenrengi Muha…

F1000Research

PMID 41179234
Semax2025
The Effect of Peptide Semax, an ACTH(4-10) Analogue, on Intracellular Calcium Dynamics in Rat Brain Neurons.

Kolbaev S N, Sharonova I N, Skrebitsky V G

Bulletin of experimental biology and medicine

PMID 41171324
Semax2025
Genes That Associated with Action of ACTH-like Peptides with Neuroprotective Potential in Rat Brain Regions with Different Degrees of Ischemic Damage.

Filippenkov Ivan B, Shpetko Yana Yu, Ales Daria A et al.

International journal of molecular sciences

PMID 40650034
Semax2025
Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing.

Tomasello Marianna Flora, Di Rosa Maria Carmela, Naletova…

Bioinorganic chemistry and applications

PMID 40496623
Semax2025
The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease.

Radchenko A I, Kuzubova E V, Apostol A A et al.

Acta naturae

PMID 41479572
Semax2022
Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models.

Sciacca Michele F M, Naletova Irina, Giuffrida Maria Laur…

ACS chemical neuroscience

PMID 35080861
Semax2024
Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress.

Inozemtseva Ludmila S, Yatsenko Ksenia A, Glazova Natalya…

European journal of pharmacology

PMID 39442746
Semax2023
Synthetic corticotropins and the GABA-receptor system: Direct and delayed effects.

Vyunova Tatiana V, Andreeva Ludmila A, Shevchenko Konstan…

Chemical biology & drug design

PMID 36828803
Semax2024
ACTH-like Peptides Compensate Rat Brain Gene Expression Profile Disrupted by Ischemia a Day After Experimental Stroke.

Filippenkov Ivan B, Shpetko Yana Yu, Stavchansky Vasily V…

Biomedicines

PMID 39767736
Semax2023
Synthetic Adrenocorticotropic Peptides Modulate the Expression Pattern of Immune Genes in Rat Brain following the Early Post-Stroke Period.

Filippenkov Ivan B, Remizova Julia A, Stavchansky Vasily …

Genes

PMID 37510287
Sermorelin1999
Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.

Prakash A, Goa K L

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

PMID 18031173
Sermorelin2017
Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels.

Sigalos John T, Pastuszak Alexander W, Allison Andrew et al.

American journal of men's health

PMID 28830317
Sermorelin2020
Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.

Sinha Deepankar K, Balasubramanian Adithya, Tatem Alexand…

Translational andrology and urology

PMID 32257855
Sermorelin2026
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.

Coutinho Luis F D, DE Oliveira Neves Lucas F, Camilo Rafa…

The Journal of sports medicine and physical fitness

PMID 41880199
Sermorelin2021
Advances in the detection of growth hormone releasing hormone synthetic analogs.

Memdouh Siham, Gavrilović Ivana, Ng Kelsey et al.

Drug testing and analysis

PMID 34665524
Sermorelin2023
Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.

Cristea Cătălina-Diana, Radu Mihai, Toboc Ani et al.

Analytical biochemistry

PMID 37806509
Sermorelin2026
Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.

Uçaktürk Ebru, Nemutlu Emirhan

Journal of pharmaceutical and biomedical analysis

PMID 41138283
Sermorelin2024
Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.

Thomas Andreas, Walpurgis Katja, Thevis Mario

Journal of mass spectrometry : JMS

PMID 38197510
Sermorelin2022
An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.

Coppieters Gilles, Deventer Koen, Polet Michaël et al.

Journal of pharmaceutical and biomedical analysis

PMID 35298973
Sermorelin2021
A potentially effective drug for patients with recurrent glioma: sermorelin.

Chang Yuanhao, Huang Ruoyu, Zhai You et al.

Annals of translational medicine

PMID 33842627
Sermorelin2016
Operation resistance: A snapshot of falsified antibiotics and biopharmaceutical injectables in Europe.

Venhuis Bastiaan J, Keizers Peter H J, Klausmann Rüdiger …

Drug testing and analysis

PMID 26456392
Sermorelin2026
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

Mendias Christopher L, Awan Tariq M

Sports medicine (Auckland, N.Z.)

PMID 41966639
MOTS-c2023
MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.

Zheng Yuejun, Wei Zilin, Wang Tianhui

Frontiers in endocrinology

PMID 36761202
MOTS-c2023
Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging.

Wan Wei, Zhang Lieliang, Lin Yue et al.

Journal of translational medicine

PMID 36670507
MOTS-c2026
Aerobic exercise and MOTS-c attenuate diabetic myocardial fibrosis via inhibition of the THBS1/TGF-β signaling pathway.

Li Zhiyu, Wang Tutu, Fu Yu et al.

Frontiers in endocrinology

PMID 41710402
MOTS-c2020
Adiponectin treatment improves insulin resistance in mice by regulating the expression of the mitochondrial-derived peptide MOTS-c and its response to exercise via APPL1-SIRT1-PGC-1α.

Guo Qi, Chang Bo, Yu Qiong-Li et al.

Diabetologia

PMID 32880686
MOTS-c2019
The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivity.

Kim Su-Jeong, Miller Brendan, Mehta Hemal H et al.

Physiological reports

PMID 31293078
MOTS-c2021
MOTS-c interacts synergistically with exercise intervention to regulate PGC-1α expression, attenuate insulin resistance and enhance glucose metabolism in mice via AMPK signaling pathway.

Yang Boyu, Yu Qiongli, Chang Bo et al.

Biochimica et biophysica acta. Molecular basis of disease

PMID 33722744
MOTS-c2022
The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitus.

Yin Yadong, Pan Yihui, He Jin et al.

Pharmacological research

PMID 34798268
MOTS-c2021
A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c.

Zempo Hirofumi, Kim Su-Jeong, Fuku Noriyuki et al.

Aging

PMID 33468709
MOTS-c2018
Plasma MOTS-c levels are associated with insulin sensitivity in lean but not in obese individuals.

Cataldo Luis Rodrigo, Fernández-Verdejo Rodrigo, Santos J…

Journal of investigative medicine

PMID 29593067
MOTS-c2026
Systemic MOTS-c levels are increased in adults with obesity in association with metabolic dysregulation and remain unchanged after weight loss.

Yoon Se-Hee, Yuan Fei, Zhu Xiangyang et al.

Journal of clinical & translational endocrinology

PMID 41551324
MOTS-c2025
MOTS-C levels in individuals with and without obesity and its association with inflammation, insulin resistance and endothelial dysfunction.

Ozkaya Duygu Yildiz, Haymana Cem, Demirci Ibrahim et al.

Archives of endocrinology and metabolism

PMID 41004666
MOTS-c2026
Are serum MOTS-c levels and MOTS-c m.1382A>C polymorphism related to polycystic ovary syndrome?

Filibeli Berna Eroğlu, Dedemoglu Fatima, Garipcin Pinar e…

Archives of endocrinology and metabolism

PMID 41945630
MOTS-c2026
Reduced serum and skeletal muscle MOTS-c levels in women with polycystic ovary syndrome are associated with mitochondrial dysfunction.

Kutuk Irem Sonmezoglu, Akin Senay, Demirel Haydar et al.

Scientific reports

PMID 41680431
MOTS-c2021
Relationship between the mitochondria-derived peptide MOTS-c and insulin resistance in obstructive sleep apnea.

Baylan Filiz Alkan, Yarar Esra

Sleep & breathing

PMID 33394327
MOTS-c2023
The relationship of circulating MOTS-c level with liver fibrosis and metabolic components in patients with metabolic dysfunction-associated fatty liver disease.

Kirik A, Dogru T, Yanik B et al.

European review for medical and pharmacological sciences

PMID 37750635
MOTS-c2025
Serum Mitochondrial Open Reading Frame of the 12S rRNA-c (MOTS-c) Dynamics as a Complementary Marker of Treatment Response in Newly Diagnosed Multiple Myeloma: A Prospective Analysis.

Erol Veysel, Avci Esin, Kabukcu Hacioglu Sibel et al.

Cureus

PMID 41479490
MOTS-c2026
MOTS-c improves intrinsic muscle mitochondrial bioenergetic health and efficiency in a PGC-1α/AMPK-dependent manner.

Gudiksen Anders, Hansen Camilla Collin, van der Stede Thi…

Free radical biology & medicine

PMID 41520850
MOTS-c2024
An 8-Week study on the effects of high and Moderate-Intensity interval exercises on mitochondrial MOTS-C changes and their relation to metabolic markers in male diabetic sand rats.

Parseh Sahar, Shakerian Saeid, Reza Tabandeh Mohammad et al.

Diabetes research and clinical practice

PMID 38636847
MOTS-c2026
Exogenous MOTS-c mitigates myocardial ischemia-reperfusion injury: experimental and in silico evidence from rat heart models.

Santhanam Saranya Sri, Jayaraman Srijan, Kurian Gino A

Naunyn-Schmiedeberg's archives of pharmacology

PMID 41593376
MOTS-c2022
MOTS-c and Exercise Restore Cardiac Function by Activating of NRG1-ErbB Signaling in Diabetic Rats.

Li Shunchang, Wang Manda, Ma Jiacheng et al.

Frontiers in endocrinology

PMID 35370955
MOTS-c2026
Mitochondrial-derived peptide MOTS-c targets SLC7A11 to preserve spermatogenesis by suppressing ferroptosis.

Liu Shuai, Ru Kang, Shen Yu-Jie et al.

Free radical biology & medicine

PMID 41933740
MOTS-c2026
MOTS-c primes adrenal cortex metabolism without directly driving steroidogenesis.

Blatkiewicz Malgorzata, Kaminski Kacper, Sobalska-Kwapis …

Folia histochemica et cytobiologica

PMID 41811086
MOTS-c2026
Mitochondrial-derived peptides MOTS-c and humanin attenuate dexamethasone-induced atrophy in human skeletal muscle cells.

Elhusseiny Rabie, Ihsan Mohammed, Bellefroid Théo et al.

Physiological reports

PMID 41732124
MOTS-c2026
Mitochondria-derived peptide MOTS-c alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice by activating Nrf2 pathway.

Chen Dan, Zhou Mei-Hui, Zhu Wei-Ying et al.

European journal of pharmacology

PMID 41802484
MOTS-c2026
MOTS-c Protects Against Acetaminophen-induced Liver Injury through the MAPK Signaling Pathway.

Li Nan, Xu Yimin, Chen Qixin et al.

Protein and peptide letters

PMID 41764620
MOTS-c2026
Therapeutic Effects of MOTS-c in the Valproic Acid-Induced Autism Model in Rats: Role of Tetrahydrobiopterin and Brain-Derived Neurotrophic Factor.

Güvenir Seven Sıla, Sahin Hakan, Erkanlı Şentürk Gözde et…

Molecular neurobiology

PMID 41706383
MOTS-c2026
MOTS-c attenuates cardiac dysfunction following high altitude exposure by promoting mitophagy.

Feng Zihang, Xing Yuan, Lou Jing et al.

Free radical biology & medicine

PMID 41654147
MOTS-c2019
MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction.

Lu Huanyu, Wei Ming, Zhai Yue et al.

Journal of molecular medicine (Berlin, Germany)

PMID 30725119
MOTS-c2019
Earlier changes in mice after D-galactose treatment were improved by mitochondria derived small peptide MOTS-c.

Li Qingyang, Lu Huanyu, Hu Guangyu et al.

Biochemical and biophysical research communications

PMID 30967270
Kisspeptin2026
Kisspeptin made in the preoptic area is required for normal estradiol-induced LH surges and optimal fertility in females.

Puffer Marina S, Yang Jason, Esparza Lourdes A et al.

Endocrinology

PMID 42057695
Kisspeptin2026
Analysis and Characterization of Kisspeptin and Its Analogues in Serum and Urine Samples by Liquid Chromatography-High-Resolution Mass Spectrometry for Doping Control Purposes.

Krombholz Sophia, Korsmeier Linus, Thomas Andreas et al.

Drug testing and analysis

PMID 42057309
Kisspeptin2026
Kisspeptin exacerbates androgen-induced follicular dysplasia by promoting Drp1 phosphorylation imbalance and mitochondrial excessive fission in granulosa cells of polycystic ovary syndrome.

Li Xiaoyan, He Ying, Wang Yiran et al.

Journal of ovarian research

PMID 42057167
Kisspeptin2026
Photoperiodic modulation of puberty through melatonin-kisspeptin-GnRH signalling in female Wistar rats.

Shah Harsh, Dan Nehareeka, Salunke Ankita et al.

Photochemical & photobiological sciences

PMID 42018125
Kisspeptin2026
Serum kisspeptin levels in pregnant and non-pregnant diestrus bitches: a pilot study.

Coppola Temy, Barbato Olimpia, Menchetti Laura et al.

Frontiers in veterinary science

PMID 42003949
Kisspeptin2026
Kisspeptin-10 attenuates pulmonary arterial hypertension via restoration of mitochondrial function in pulmonary artery smooth muscle cells.

Huang Sijia, Chen Zixuan, Gong Wanwei et al.

Neuropeptides

PMID 41955717
Kisspeptin2026
Kisspeptin-10 Promotes Hormone Secretion, Ovarian Follicles Development and Fecundity via PI3K/AKT/ERK Signal Pathway in Mice.

Suocheng Wei, Linglong Xu, Jingshuang Gao et al.

Molecular reproduction and development

PMID 41952615
Kisspeptin2026
Kisspeptin-54 confers renal protection in diabetic nephropathy by ameliorating endothelial permeability through ZEB1 inhibition.

Gao Lichao, Lv Qiang, Wang Yujie et al.

Tissue & cell

PMID 41950743
Kisspeptin2026
Serum kisspeptin levels in women with polycystic ovary syndrome: A systematic review and meta-analysis.

Siahaan S C, Sa'adi A, Hendarto H et al.

The Medical journal of Malaysia

PMID 41914593
Kisspeptin2026
GH and GnRH-gonadotropin secretion.

Lages Adriana De Sousa, Lopes Valentim, Anderson Richard

Vitamins and hormones

PMID 41912296
Kisspeptin2026
GABA receptor modulation of arcuate kisspeptin neuron bursting and synchronization activity in female mice.

Eddleston Toby, Morris Paul G, Herbison Allan E

Journal of neuroendocrinology

PMID 41912143
Kisspeptin2026
Robust serotonin activation of the kisspeptin GnRH pulse generator in male and female mice.

Morris Paul G, Liu Xinhuai, Birt Emily et al.

Endocrinology

PMID 41906629
Kisspeptin2026
Integrating mechanistic models to decode the GnRH pulse generator in female mice.

Nechyporenko Kateryna, Ivanova Deyana, Li Xiao Feng et al.

Journal of molecular endocrinology

PMID 41988873
CJC-12952026

Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.

Mavrych Volodymyr, Shypilova Inna, Bolgova Olena

Frontiers in aging

PMID 42021992
CJC-12952026

Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

Mendias Christopher L, Awan Tariq M

Sports medicine (Auckland, N.Z.)

PMID 41966639
CJC-12952026

A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.

Coutinho Luis F D, DE Oliveira Neves Lucas F, Camilo Rafa…

The Journal of sports medicine and physical fitness

PMID 41880199
CJC-12952026

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

Rahman Omar F, Lee Steven J, Seeds William A

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews

PMID 41490200
CJC-12952026

Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.

Mayfield Cory K, Bolia Ioanna K, Feingold Cailan L et al.

The American journal of sports medicine

PMID 41476424
CJC-12952026

Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.

Uçaktürk Ebru, Nemutlu Emirhan

Journal of pharmaceutical and biomedical analysis

PMID 41138283
CJC-12952024

Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.

Thomas Andreas, Walpurgis Katja, Thevis Mario

Journal of mass spectrometry : JMS

PMID 38197510
CJC-12952023

Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.

Cristea Cătălina-Diana, Radu Mihai, Toboc Ani et al.

Analytical biochemistry

PMID 37806509
CJC-12952022

Probing for peptidic drugs (2-10 kDa) in doping control blood samples.

Thomas Andreas, Thilmany Sam, Hofmann Amelie et al.

Analytical science advances

PMID 38716080
CJC-12952022

An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.

Coppieters Gilles, Deventer Koen, Polet Michaël et al.

Journal of pharmaceutical and biomedical analysis

PMID 35298973
CJC-12952022

Early detection of cannabinoids in biological samples based on their affinity interaction with the growth hormone secretagogue receptor.

Danila George Madalin, Puiu Mihaela, Zamfir Lucian-Gabrie…

Talanta

PMID 34736642
CJC-12952021

Advances in the detection of growth hormone releasing hormone synthetic analogs.

Memdouh Siham, Gavrilović Ivana, Ng Kelsey et al.

Drug testing and analysis

PMID 34665524
CJC-12952020

Comparison of magnetic bead surface functionalities for the immunopurification of growth hormone-releasing hormones prior to liquid chromatography-high resolution mass spectrometry.

Pont Laura, Alechaga Élida, Terrero Alejandro et al.

Journal of chromatography. A

PMID 32971474
CJC-12952019

A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS.

Timms Mark, Ganio Katherine, Steel Rohan

Drug testing and analysis

PMID 30938069
CJC-12952019

An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma.

Timms Mark, Ganio Katherine, Forbes Grace et al.

Drug testing and analysis

PMID 30489688
CJC-12952016

The study of doping market: How to produce intelligence from Internet forums.

Pineau Thomas, Schopfer Adrien, Grossrieder Lionel et al.

Forensic science international

PMID 27710891
CJC-12952016

Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS.

Knoop Andre, Thomas Andreas, Fichant Eric et al.

Analytical and bioanalytical chemistry

PMID 26879649
CJC-12952016

Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.

Van Hout Marie Claire, Hearne Evelyn

Substance use & misuse

PMID 26771670
CJC-12952015

Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS.

Thomas Andreas, Walpurgis Katja, Tretzel Laura et al.

Drug testing and analysis

PMID 26382721
CJC-12952014

Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions.

Thevis Mario, Thomas Andreas, Schänzer Wilhelm

Expert review of proteomics

PMID 25382550